OakChart

Innovate Corp

VATEIndustrials·Engineering & Construction·USA·Micro·NYSE·Nov 11 • 3:59 PM ET

5.27+0.16 (3.13%)
2026-11-12 02:13 CET
Market cap
69.71 USD m
Revenue, TTM
1,516.20 USD m
Net income, TTM
-24.00 USD m
Free cash flow, TTM
106.00 USD m
EPS diluted, TTM
-1.84
P/E
-
Compare

Price

VATE against its 20, 50 and 200-day averages
2050200earnings
5.0010.0015.0020.007.1M14.3MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26VATEclose 5.2720-day 5.6250-day 6.66200-day 8.815.2752w high

75.3% under the 52-week high of 21.30 on 18 Jun 2026. 52-week low 3.41 on 23 Mar 2026. Last 15 sessions, 25.8% high to low

Volume 0.42× normal · the line is the 50-bar volume average

Profile

VATE
52-week range, 10% of the way up
3.4121.30

INNOVATE Corp. is a diversified holding company, which engages in the acquisition and investment of assets. It operates through the following segments: Infrastructure, Life Sciences, Spectrum, and Other. The Infrastructure segment consists of DBM Global Inc. and its wholly owned subsidiaries. The Life Sciences segment refers to Pansend Life Sciences LLC, its subsidiaries, and its equity investments. The Spectrum segment focuses on HC2 Broadcasting Holdings Inc. and its subsidiaries. The Other segment represents all other businesses or investments that do not meet the definition of a segment individually or in aggregate. The company was founded on February 4, 1994 and is headquartered in New York, NY.

IndexRUT
Employees3738
IPOJul 13, 2009
Beta2.76
ATR, 14d0.41
Rel volume0.42
Short float11.02%
Insider own64.03%
Inst own28.34%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap71.89M
Enterprise Value689.59M
Income-24.00M
Sales1.52B
Book/sh-17.83
Cash/sh6.44
Dividend Est.-
Dividend TTM-
Dividend Ex-DateAug 28, 2013
Dividend Gr. 3/5Y- -
Payout-
Employees3738
IPOJul 13, 2009

Ratios

P/E-
Forward P/E-
PEG-
P/S0.05
P/B-
P/C0.82
P/FCF0.68
EV/EBITDA6.95
EV/Sales0.45
Quick Ratio0.43
Current Ratio0.44
Debt/Eq-
LT Debt/Eq-
Option/ShortNo / Yes

Earnings

EPS (ttm)-1.84
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y2.52% 13.79%
Sales past 3/5Y-8.70% 11.69%
EPS Y/Y TTM70.10%
Sales Y/Y TTM52.38%
EPS Q/Q144.50%
Sales Q/Q74.21%
EarningsNov 12 AMC
EPS/Sales Surpr.- -

Ownership

Insider Own64.03%
Insider Trans0.00%
Inst Own28.34%
Inst Trans21.99%
ROA-2.36%
ROE-
ROIC-
Gross Margin14.85%
Oper. Margin4.60%
Profit Margin-1.58%
SMA20-6.18%
SMA50-20.82%
SMA200-40.16%
Trades-

Technical

Shs Outstand13.64M
Shs Float4.91M
Short Float11.02%
Short Ratio4.83
Short Interest0.54M
52W High21.30 -75.26%
52W Low3.41 54.62%
Volatility7.61% 6.73%
ATR (14)0.41
RSI (14)38.25
Beta2.76
Rel Volume0.42
Avg Volume112.07K
Volume47,089

Performance

Perf Week-2.95%
Perf Month-17.40%
Perf Quarter-29.83%
Perf Half Y-55.19%
Perf YTD28.28%
Perf Year5.42%
Perf 3Y-49.14%
Perf 5Y-87.48%
Perf 10Y-87.23%
Recom1.00
Target Price8.49
Prev Close5.11
Price5.27
Change %3.13%

Peers

Mkt cap
TickerCompanyMkt cap
IESCIES Holdings Inc7.14B
BOCBoston Omaha Corp413.94M
MTRXMatrix Service Co259.39M
CODICompass Diversified Holdings917.88M
STRRStar Equity Holdings Inc32.95M
ORNOrion Group Holdings Inc315.92M
SSPE.W. Scripps Co348.44M
GEGGreat Elm Group Inc66.32M
GTNGray Media Inc610.37M
IEPIcahn Enterprises L P3.79B

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
BUSMEA Bridgeway Ultra-Small Company Market ETFAUM: 111.21M
IWCiShares Micro-Cap ETFAUM: 1.22B
VTWGVanguard Russell 2000 Growth Index ETFAUM: 1.41B
RSSLGlobal X Russell 2000 ETFAUM: 1.43B
VTHRVanguard Russell 3000 Index ETFAUM: 4.81B

News

latest 14 of 200
  • INNOVATE Corp. to Report Third Quarter 2026 Results on November 12th (GlobeNewswire) -8.47% +5.84%
  • INNOVATE Completes Sale of DBM Global to IES Holdings (GlobeNewswire)
  • Top Research Reports for AMD, Linde & Amgen (Zacks)
  • INNOVATE Announces Closing of the Sale of a Controlling Interest in its Broadcasting Segment to CONX (GlobeNewswire)
  • MediBeacon Transdermal GFR System Nominated for 2026 Prix Galien USA Best Medical Technology (GlobeNewswire)
  • INNOVATE Agrees to $650 Million Sale of DBM Global to IES Holdings (GlobeNewswire) -41.12%
  • Innovate Corp (VATE) (Q2 2026) Earnings Call Highlights: Record Infrastructure Performance and ... (GuruFocus.com) +63.43%
  • INNOVATE Corp. Announces Second Quarter 2026 Results (GlobeNewswire)
  • INNOVATE Corp. to Report Second Quarter 2026 Results on August 6th (GlobeNewswire) -10.10% +6.85%
  • INNOVATE's Portfolio Company DBM Global to Pay Cash Dividend (GlobeNewswire) -16.14% -11.11%
  • INNOVATE Announces Successful Closing of Broadcasting Refinancing and Agrees to Partial Sale of Broadcasting (GlobeNewswire)
  • Innovate Corp (VATE) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic Advances ... (GuruFocus.com) -8.73%
  • INNOVATE Corp. Announces First Quarter 2026 Results (GlobeNewswire)
  • INNOVATE Corp. to Report First Quarter 2026 Results on May 14th (GlobeNewswire) -7.54%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q12026-05-14---1.290364.8--
2025Q42026-03-26---0.580382.7--
2025Q32025-11-12---0.710347.1--
2025Q22025-08-05---1.670242--
2025Q12025-05-06---1.890274.2--
2024Q42025-03-31---1.290236.6--
2024Q32024-11-06---1.180242.2--
2024Q22024-08-07--0.100313.1--
2024Q12024-05-07---0.220315.2--
2023Q42024-03-04---0.120361--
2023Q32023-11-09---0.090375.3--
2023Q22023-08-09---0.130368.8--
2023Q12023-05-10---0.130317.9--
2022Q42023-03-14---0.090409.3--
2022Q32022-11-02---0.090423--
2022Q22022-08-03---0.180392.2--

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2012FY-33.049-35.54520.169260.55259
2014FY-7.089--7.189543.2-
2015FY-14.977--14.9171,121-
2016FY-28.256-11.782-28.0411,5581,499
2017FY-11.600-11.083-11.4991,6341,608
2018FY28.97636.04428.7441,9771,939
2019FY-0.660--6.9701,984-
2020FY-7.546--10.1651,006-
2021FY-1.050--2.9801,205-

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
No estimate revisions.

Estimate history

EPS, annual-11.49928.744-6.97-10.165-8.988-5.227-4.78-3.347-4.842-1.8376
Period201720182019202020212022202320242025TTM
EPS, quarterly0.977-1.18-1.292-1.891-1.673-0.709-0.585-1.2890.745
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual1634.1231978.21079.2716.91205.21637.314231107.112461516.2
Period201720182019202020212022202320242025TTM
Sales, quarterly313.1242.2236.6274.2242347.1382.7364.8421.6
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual4.4584.534.6477.7287.847.9367.98113.26113.65513.642
Period201720182019202020212022202320242025MRQ
Shares, quarterly13.05313.16613.26113.28313.33613.65513.65513.64213.642
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue1,516.201,246.001,107.101,423.001,637.301,205.20716.901,079.201,978.20
Cost of Goods Sold Incl. D&A1,291.001,063.80915.901,227.201,443.101,046.90606.20618.401,616.90
Gross Profit225.20182.20191.20195.80194.20158.30110.70460.80361.30
Selling, General and Administrative Excl. Other155.50148.00153.90161.80180.10168.30145.50409.50411.50
Other Operating Expense0.000.000.000.000.000.000.00-23.100.00
Operating Income69.7034.2037.3034.0014.10-10.00-34.8074.40-50.20
Interest Expense99.5089.0074.5068.2052.0059.1074.8076.1075.70
Unusual Expense-13.004.606.606.802.2013.2012.2048.908.70
Net Income Before Taxes-14.70-61.50-33.40-34.40-41.10-80.70-46.70-41.80182.30
Income Taxes7.202.506.304.500.905.607.00-19.602.40
Consolidated Net Income-21.90-64.00-39.70-38.90-42.00-86.30-53.70-22.20163.30
Net Income From Continuing Operations-22.40-60.60-34.60-35.20-35.90-77.60-43.60-17.80145.40
Net Income-24.00-64.00-35.80-37.60-40.80-69.80-51.50-31.50139.00
EPS (Recurring)-2.37-4.60-2.92-4.17-5.03-7.80-8.480.6030.03
EPS (Basic, Before Extraordinaries)-1.80-4.84-3.35-4.78-5.23-8.99-10.17-6.9731.10
EPS (Diluted)-1.84-4.84-3.35-4.78-5.23-8.99-10.17-6.9728.74
EBITDA99.2064.6070.2070.0056.3027.60-8.00105.901.30
Non-Operating Income (Expense)2.10-2.1010.406.60-1.001.6075.108.80316.90
Other After Tax Adjustments0.000.000.000.000.000.000.000.00-16.60
Stock Option Compensation Expense1.742.132.691.741.901.752.194.537.11
Price To Earnings Ratio--------0.91
Price To Sales Ratio0.170.050.050.070.090.240.230.090.06
Gross Margin14.8514.6217.2713.7611.8613.1315.4442.7018.26
Operating Margin4.602.743.372.390.86-0.83-4.856.89-2.54
Net Margin-1.58-5.14-3.23-2.64-2.49-5.79-7.18-2.927.03
Shares Outstanding13.6413.6613.267.987.947.847.734.654.53
Market Capitalization69.7169.7165.5197.46146.60288.00250.1399.97118.56

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue421.60364.80382.70347.10242.00274.20236.60242.20
Cost of Goods Sold Incl. D&A345.60315.50328.20301.70200.80233.10194.60198.40
Gross Profit76.0049.3054.5045.4041.2041.1042.0043.80
Selling, General and Administrative Excl. Other39.7038.2039.3038.3033.6036.7037.4035.40
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income36.3011.1015.207.107.604.404.608.40
Interest Expense27.6024.5024.0023.4021.4020.2019.6021.20
Unusual Expense-16.501.201.301.001.501.103.000.10
Net Income Before Taxes25.50-14.20-9.30-16.70-16.80-18.70-14.90-13.10
Income Taxes13.102.90-1.70-7.104.207.102.403.10
Consolidated Net Income12.40-17.10-7.60-9.60-21.00-25.80-17.30-16.20
Net Income From Continuing Operations10.70-16.80-7.40-8.90-19.80-24.50-16.60-15.00
Net Income10.40-17.20-7.80-9.40-22.00-24.80-16.90-15.30
EPS (Recurring)-0.08-1.23-0.52-0.66-1.59-1.83-1.13-1.17
EPS (Basic, Before Extraordinaries)0.78-1.29-0.58-0.71-1.67-1.89-1.29-1.18
EPS (Diluted)0.74-1.29-0.58-0.71-1.67-1.89-1.29-1.18
EBITDA43.3018.5022.8014.6015.0012.3012.7016.50
Non-Operating Income (Expense)0.300.400.800.60-1.50-1.803.10-0.20
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.320.470.400.550.550.631.820.24
Price To Sales Ratio0.170.060.050.060.070.100.060.04
Gross Margin18.0313.5114.2413.0817.0214.9917.7518.08
Operating Margin8.613.043.972.053.141.601.943.47
Net Margin2.47-4.71-2.04-2.71-9.09-9.04-7.14-6.32
Shares Outstanding13.6413.6413.6613.6613.3413.2813.2613.17
Market Capitalization69.7177.5061.7265.2168.41103.8465.5148.30

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments112.1048.8081.7080.7047.5045.30193.70325.0097.89
Short Term Receivables309.60300.90399.10420.00365.70221.301,182.60379.20322.45
Inventories16.0020.8022.4018.9017.009.9010.7021.3012.74
Other Current Assets13.8020.4014.7016.8012.405,950.80---
Total Current Assets451.50390.90517.90536.40442.606,227.301,387.00725.50433.07
Net Property, Plant & Equipment194.70187.30212.60230.80239.50152.60176.90376.30374.66
Total Investments and Advances2.404.102.4061.5058.0056.904,393.503,828.401,543.60
Long-Term Note Receivable-----55.6050.601,069.20526.34
Intangible Assets292.20299.10306.00317.20335.80283.10321.00390.90248.85
Deferred Tax Assets2.001.602.001.703.003.002.802.101.66
Other Assets7.308.102.704.101.700.90626.50111.4089.52
Total Assets950.10891.101,043.601,151.701,080.606,723.806,958.306,503.803,217.69
Short Term Debt Incl. Current Port. of LT Debt594.30175.1044.0047.7085.00444.800.00169.50154.65
Accounts Payable141.4084.80142.90202.50179.2069.704,872.10104.70119.24
Income Tax Payable0.600.800.400.400.400.601.900.806.44
Other Current Liabilities297.80222.30226.50166.60174.905,418.10341.205,291.302,201.91
Total Current Liabilities1,034.10483.00413.80417.20439.505,933.205,215.205,566.302,482.23
Long Term Debt123.20544.10727.90737.60615.30159.50774.90574.40438.52
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities4.704.404.109.109.107.0081.6030.3010.74
Other Liabilities3.403.3034.1017.404.808.20421.40110.8070.17
Total Liabilities1,165.401,034.801,179.901,181.301,068.706,107.906,493.106,281.803,001.66
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value9.3016.1016.4017.6018.8010.4010.3020.3026.30
Common Equity-240.10-180.40-165.50-121.30-84.30559.80349.8088.1073.17
Total Shareholders Equity-230.80-164.30-149.10-103.70-65.50570.20360.10108.4099.47
Accumulated Minority Interest15.5020.6012.8074.1077.4045.70105.10113.60116.56
Total Equity-215.30-143.70-136.30-29.6011.90615.90465.20222.00216.03
Total Liabilities & Stockholders Equity950.10891.101,043.601,151.701,080.606,723.806,958.306,503.803,217.69
Book Value Per Share-17.58-13.60-20.74-15.29-10.7572.4475.2719.4516.41
Tangible Book Value Per Share-38.98-36.16-59.08-55.26-53.5935.806.20-66.84-39.41
Full-Time Employees3,7383,1614,0243,7613,9022,8033,7284,1193,358
Price to Book Ratio-0.29-0.40-0.62-1.24-3.420.450.291.354.06
Return on Assets-6.58-3.58-3.21-3.22-1.98-0.64-0.262.99-1.55
Return on Equity-----30.75-9.37-7.60139.90-54.19
Return on Invested Capital--9.11-6.08-5.66-12.30-6.56-2.7821.29-8.72
Quick Ratio0.420.771.201.240.971.050.260.130.17
Current Ratio0.440.811.251.291.011.050.270.130.17

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-21.90-64.00-39.70-38.90-42.00-86.30-53.70-22.20179.90
Depreciation29.5030.4032.9036.0042.2037.6026.808.2038.70
Other Funds (Non Cash)12.0029.103.306.609.20122.8057.90133.80-204.60
Funds from Operations19.30-4.60-3.00-1.6010.5076.1026.3092.6011.40
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital121.90151.2012.1028.10-20.0013.4014.8018.10330.00
Cash from Operating Activities141.20146.609.1026.50-9.5089.5041.10110.70341.40
Capital Expenditures-35.20-26.10-20.20-18.40-20.70-24.10-17.80-24.70-39.70
Net Assets From Acquisitions-0.50-0.50-0.30-15.900.00-142.00-62.90-25.50-12.30
Sale of Fixed Assets and Businesses0.301.4010.101.602.0087.20188.6014.80670.00
Purchase or Sale of Investments2.402.60-4.3055.20-4.500.0086.10-187.90-855.30
Purchase of Investments-0.50-0.30-4.30-4.00-4.500.000.00-1,060.10-1,186.40
Sale Or Maturity of Investments2.902.900.0059.200.000.0086.10872.20331.10
Other Uses0.000.000.000.000.00-221.30-99.80-54.400.00
Other Sources0.000.000.500.700.701.005.008.400.40
Cash from Investing Activities-33.00-22.60-14.2023.20-22.50-299.2099.20-269.30-236.90
Cash Dividends Paid-1.80-2.20-1.20-2.20-5.200.000.000.00-2.00
Change in Capital Stock-2.800.000.00-7.000.000.1075.200.60-5.80
Repurchase of Common Pref Stock0.000.000.00-7.000.00-10.400.00-8.30-5.80
Sale of Common Pref Stock-2.800.000.000.000.0010.5075.208.900.00
Proceedsfrom Stock Options-2.800.000.000.000.0010.5075.208.900.00
Issuance or Reduction of Debt, Net-46.30-58.30-58.20-39.9074.0029.50-186.0059.40153.60
Change in Long Term Debt-46.30-58.30-58.20-39.9074.0029.50-186.0059.40153.60
Issuance of Long Term Debt120.20107.2094.8091.90187.40487.600.0088.90850.60
Reduction of Long Term Debt-166.50-165.50-153.00-131.80-113.40-458.10-186.00-29.50-697.00
Net Financing Active Other Cash Flow-0.70-0.7033.20-0.30-0.70-11.80-30.808.10-18.30
Other Financing Activities Uses-0.70-0.700.00-0.30-0.70-11.80-30.80-22.80-20.70
Cash from Financing Activities-51.60-61.20-26.20-49.4068.1017.80-141.6068.10127.50
Exchange Rate Effect-0.200.60-1.70-0.20-1.40-1.301.100.70-0.50
Net Change in Cash56.4063.40-33.000.1034.70-193.20-0.20-89.80231.50
Free Cash Flow106.00120.50-11.108.10-30.2065.4023.3086.00301.70
Preferred Dividends (Cash Flow)-------0.00-
Price to Free Cash Flow2.500.51-16.28-4.367.041.130.41
Deferred Taxes & Investment Tax Credit--0.100.50-5.301.102.00-4.70-27.20-2.60

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments87.80134.60112.1035.5033.4033.30
Short Term Receivables338.80241.80309.60349.00327.80300.30
Inventories14.8015.4016.0018.1020.7019.70
Other Current Assets37.9014.1013.8018.0016.5018.20
Total Current Assets479.30405.90451.50420.60398.40371.50
Net Property, Plant & Equipment200.30232.10194.70186.40182.10185.60
Total Investments and Advances2.802.402.402.405.004.70
Intangible Assets149.70290.80292.20293.90295.50297.10
Deferred Tax Assets2.002.002.001.601.601.60
Other Assets172.603.607.308.308.307.50
Total Assets1,006.70936.80950.10913.20890.90868.00
Short Term Debt Incl. Current Port. of LT Debt564.40624.70594.30584.50490.30536.40
Accounts Payable137.20130.20141.4099.9080.20104.70
Income Tax Payable12.500.300.602.509.907.00
Other Current Liabilities369.30264.60297.80287.40292.70199.50
Total Current Liabilities1,083.401,019.801,034.10974.30873.10847.60
Long Term Debt117.90140.80123.20139.20199.60181.80
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities1.904.704.704.304.504.50
Other Liabilities23.503.703.403.103.003.00
Total Liabilities1,226.701,169.001,165.401,120.901,080.201,036.90
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value9.709.509.309.1017.9016.10
Common Equity-243.20-256.30-240.10-233.30-224.80-204.20
Total Shareholders Equity-233.50-246.80-230.80-224.20-206.90-188.10
Accumulated Minority Interest13.5014.6015.5016.5017.6019.20
Total Equity-220.00-232.20-215.30-207.70-189.30-168.90
Total Liabilities & Stockholders Equity1,006.70936.80950.10913.20890.90868.00
Book Value Per Share-17.83-18.79-17.58-17.09-16.86-15.37
Tangible Book Value Per Share-28.80-40.10-38.98-38.61-39.01-37.74
Full-Time Employees--3,738---
Price to Book Ratio-0.29-0.32-0.26-0.29-0.34-0.58
Return on Assets-2.36-5.86-6.58-7.71-8.48-4.60
Quick Ratio0.430.380.420.410.430.42
Current Ratio0.440.400.440.430.460.44

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income12.40-17.10-7.60-9.60-21.00-25.80
Depreciation7.007.407.607.507.407.90
Other Funds (Non Cash)-7.506.706.706.108.308.00
Funds from Operations11.80-3.006.703.80-5.30-9.80
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-36.4048.5094.4015.4045.70-4.30
Cash from Operating Activities-24.6045.50101.1019.2040.40-14.10
Capital Expenditures-10.40-9.50-7.50-7.80-6.10-4.70
Net Assets From Acquisitions-0.10-0.200.00-0.20-0.300.00
Sale of Fixed Assets and Businesses0.000.100.000.200.101.10
Purchase or Sale of Investments-0.500.000.002.900.00-0.30
Purchase of Investments-0.500.000.000.000.00-0.30
Sale Or Maturity of Investments0.000.000.002.900.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-11.00-9.60-7.50-4.90-6.30-3.90
Cash Dividends Paid-0.30-0.40-0.70-0.40-0.80-0.30
Change in Capital Stock-2.800.000.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock-2.800.000.000.000.000.00
Proceedsfrom Stock Options-2.800.000.000.000.000.00
Issuance or Reduction of Debt, Net-6.00-13.00-15.90-11.40-33.802.80
Change in Long Term Debt-6.00-13.00-15.90-11.40-33.802.80
Issuance of Long Term Debt105.000.000.5014.7072.0020.00
Reduction of Long Term Debt-111.00-13.00-16.40-26.10-105.80-17.20
Net Financing Active Other Cash Flow0.00-0.10-0.50-0.100.00-0.10
Other Financing Activities Uses0.00-0.10-0.50-0.100.00-0.10
Cash from Financing Activities-9.10-13.50-17.10-11.90-34.602.40
Exchange Rate Effect-0.100.100.10-0.300.600.20
Net Change in Cash-44.8022.5076.602.100.10-15.40
Free Cash Flow-35.0036.0093.6011.4034.30-18.80
Price to Free Cash Flow2.500.440.511.114.43-

Revenue breakdown

United States2024: 1.11B 2025: 1.25B
Infrastructure2024: 1.07B 2025: 1.21B
Life Sciences2024: 9.80M 2025: 12.50M
Spectrum2024: 25.70M 2025: 23.20M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3011.02%0.5M4.9M369.60K
2026-10-1511.35%0.6M4.9M374.09K
2026-09-3011.31%0.6M4.9M386.53K
2026-09-1512.22%0.6M4.9M399.29K
2026-08-3111.12%0.5M4.9M391.76K
2026-08-1410.04%0.5M4.9M380.57K
2026-07-318.65%0.4M5.1M93.38K
2026-07-158.99%0.5M5.1M88.40K
2026-06-307.79%0.4M5.1M80.90K
2026-06-154.87%0.2M5.1M58.70K
2026-05-294.80%0.2M5.1M49.85K
2026-05-155.24%0.3M5.1M42.69K
2026-04-305.29%0.3M5.1M36.50K
2026-04-156.14%0.3M4.9M28.91K
2026-03-315.91%0.3M4.9M19.18K
2026-03-135.81%0.3M4.9M22.32K
2026-02-275.85%0.3M4.9M23.14K
2026-02-135.84%0.3M4.9M22.55K
2026-01-305.87%0.3M4.9M23.14K
2026-01-156.03%0.3M4.9M30.55K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-098-KCurrent report2026-10-09SEC
2026-10-058-KCurrent report2026-10-02SEC
2026-09-174Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-09-03DEF 14CInformation Statement Pursuant to Section 14(c) of the Securities Exchange Act of 19342026-09-03SEC
2026-09-028-KCurrent report2026-08-28SEC
2026-08-24PRE 14CInformation Statement Pursuant to Section 14(c) of the Securities Exchange Act of 19342026-08-21SEC
2026-08-21EFFECTEffectiveness filing by commission orderSEC
2026-08-19S-3/ASEC
2026-08-188-KCurrent report2026-08-18SEC
2026-08-14SCHEDULE 13DSEC
2026-08-134Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-134Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-134Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-134Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-134Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-134Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-10S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-08-10424B5SEC
2026-08-108-KCurrent report2026-08-07SEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-08-038-KCurrent report2026-07-31SEC
2026-07-088-KCurrent report2026-07-08SEC
2026-06-118-KCurrent report2026-06-11SEC
2026-06-018-KCurrent report2026-05-29SEC
2026-05-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-148-KCurrent report2026-05-14SEC
2026-04-28DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-28DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342025-12-31SEC
2026-04-068-KCurrent report2026-04-06SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Whitefort Capital Management, LP5.45%
Jefferies Financial Group Inc.5.14%
BlackRock, Inc.2.60%
VANGUARD CAPITAL MANAGEMENT LLC1.68%
GEODE CAPITAL MANAGEMENT, LLC0.96%
MARSHALL WACE, LLP0.79%
STRS OHIO0.67%
BANK OF AMERICA CORP /DE/0.61%
STATE STREET CORP0.61%
RENAISSANCE TECHNOLOGIES LLC0.42%

Funds

Fund% owned
MetLife Opportunistic High Yield Fund12.37%
VANGUARD TOTAL STOCK MARKET INDEX FUND1.25%
iShares Russell 2000 ETF0.91%
Fidelity Small Cap Index Fund0.44%
PD High Yield Bond Market Portfolio0.43%
VANGUARD EXTENDED MARKET INDEX FUND0.42%
iShares Russell 2000 Growth ETF0.34%
VANGUARD RUSSELL 2000 INDEX FUND0.23%
Ultra-Small Company Market Fund0.18%
Fidelity Extended Market Index Fund0.17%

OakChart. VATE. Cached 15 minutes.

Some panels did not load: ratings, insider.